Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines
NCT00650130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2013-11-04
Summary
The aim of this study is to get new information on the whole blood-plasma-oral fluid ratios of psychoactive drugs which are encountered in traffic.
Samples are taken from drivers suspected of being under the influence of drugs or medicines. The samples are analysed with immunological methods and GC-MS.
Observations from Police and a physician on impairment are combined with the results of the different bodily fluids. Observational evaluations and substance concentrations are compared.
Conditions
- Driving Under the Influence
Sponsors & Collaborators
-
University of Helsinki
collaborator OTHER -
Ministry of Internal Affairs, Finland
collaborator UNKNOWN - collaborator OTHER
-
Finnish Institute for Health and Welfare
lead OTHER_GOV
Principal Investigators
-
Pirjo Lillsunde, Dr · National Public Health Institute, Helsinki, Finland
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2008-12-31
- Completion
- 2011-10-31
Countries
- Finland
Study Locations
More Related Trials
-
Pilot-Study for the Comparison of Biomarkers Between Regular Cannabis Users and Non-Users
NCT06975020 ·Status: RECRUITING ·Phase: NA
-
Driving Simulator Performance After Intake of Zopiclone Sleeping Pills
NCT01257165 ·Status: WITHDRAWN ·Phase: NA
-
Study of the Relationship Between Dose-concentration-effect of Delta-9-tetrahydrocannabinol (THC) and the Ability to Drive in Chronic or Occasional Cannabis Users
NCT02061020 ·Status: COMPLETED ·Phase: NA
-
Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics
NCT02177513 ·Status: COMPLETED ·Phase: PHASE1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I
NCT02709954 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effects of Alcohol on Simulated Driving
NCT00477984 ·Status: COMPLETED ·Phase: NA
-
Cannabis Cigarettes Used for Doping: Delta-9-Tetrahydrocannabinol (THC) Urine Detection
NCT00534716 ·Status: COMPLETED
-
A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users
NCT02094599 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
NCT05032833 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim
NCT04970342 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Nitrous Oxide: A Dose-Response Analysis - 5
NCT00000253 ·Status: COMPLETED ·Phase: NA
-
PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults
NCT05906511 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Developing a Mobile Method to Measure THC-induced Impairment
NCT03804840 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Medical Students and Psychoactive Substances Use
NCT04209101 ·Status: COMPLETED
-
Pharmacokinetics of GH001 in Healthy Volunteers
NCT05163691 ·Status: COMPLETED ·Phase: PHASE1
-
Dopamine Release in the Human Brain Following Alcohol Administration
NCT01638364 ·Status: COMPLETED ·Phase: PHASE1
-
How Stress Alters Opioid Drug Effects
NCT06485817 ·Status: COMPLETED ·Phase: NA
-
Acute Dose-dependent Effects of DMT in Healthy Subjects
NCT05384678 ·Status: COMPLETED ·Phase: PHASE1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
NCT02404688 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
GHB Poisoning and Poisoning Induced by Others
NCT03651778 ·Status: COMPLETED
-
Quantification of Drugs and Their Degradation Products
NCT01828372 ·Status: UNKNOWN ·Phase: NA
-
Personality and Drug Use (PDU)
NCT05180149 ·Status: WITHDRAWN
-
Characteristics of Spiking in Ghent: a Multicentric Prospective Observational Study..
NCT06207396 ·Status: COMPLETED
-
MedDrive's Responsiveness to Alcohol
NCT01781273 ·Status: COMPLETED ·Phase: NA
-
The Effects of ∆-9-THC and Naloxone in Humans
NCT01591629 ·Status: COMPLETED ·Phase: EARLY_PHASE1